The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
No mention of PSE at all.
What a great missed opportunity OBD have made through hopeless management. One of the biggest ever perhaps, certainly in the medical field.
I hope a takeover comes very quickly
I hope for a buyout in some form by big pharma to monetize the science and for OBD to concentrate on the science. Leave marketing and shareholder dealings to business pro's. The sooner the better. This set of results damages the science aspects, never good to be a laughing stock or to embitter investors.
All the news is so good and with the new markets the brand will attract more shoppers globally enhancing the ability for more products and increased awareness of shoppers and investors imho
As it would seem most of central and south America is going or is now narco with drugs and guns and cartels being the prime movers in countries with failing economies I wonder if Argentina is at risk of Cartels taking over. The economy being shot for years and the Milei bitter medicine making it a lot worse for the average Joe. Maybe it's not reported?
I hope that we are going to get very comprehensive news on the Co's activities and sales worldwide and 'deals' with health outfits etc. There's a lot of catching up to do giving investors info as to the financial side of things (although the science is fantastic - the world is in a parlous state right now and economics a roller coaster daily) If they had good news and issued press releases the SP wouldn't have gone in the doldrums for months. The SP is getting better rapidly as we head towards results day but still just making up losses. Everyone goes on about the potential but everything has that and only a few walk the talk. Depends on what they are doing and will do. That's what makes me invest or not.
I hope it's good news for all. (Fingers crossed)
I read some reviews of the products recently and the consensus is good products at great prices, you don't get much better than that so I bought on the slight dip today (a bad market day - US inflation up) women will always buy cosmetics, (same as most blokes buy deodorant) doesn't matter if times are hard, you go downmarket a bit to save money and sometimes find out that the cheaper product is better and cheaper. I'm not a chartist but when it's consistently going north from inception and the product is popular its a no-brainer (horrible phrase).
It's my second best share after Allianz Tech Trust, the magnificent 7 and W7L - my lucky number too!
There was a bit on the news a couple of days ago, new signage to be placed in toilets 'blood in pee? see your doctor' or words to that effect. It was a sign like that that made me check, and yes I had cancer. Hopefully it's gone after treatment. But these signs will probably get more people to check and more business for OBD.
I note the SP slide and don't think any meaningful upside will come until results are published and good news.
Momentum gone for now...
Bline 59
You wrote 'On October 4th 2023.....Share Cap Investments forecast the SP would be IRO £2.08 within the next 12-18 months from that date.'
Can you (or anybody else) say who or what company exactly have said that as I'd like to read the full text.
Shame OBD is getting the same treatment as most other Bio Co's on AIM which I wouldn't normally go near, the clincher for me is the US Govt accreditation and Med Ins payback and BUPA here.
As it would seem most action is going to be in the US at least for a while, is there any info as to sales, cash coming in. A listing on main market?
I wonder also if there are any share chat boards there also.
Any info welcome even if it's no news on anything.
Thanks in advance.
Hi sheltie, I'm not too sure many investors (like me) would like to be reminded of the share price then and the subsequent crash.
As for the national roll out of MRI for prostate screening, it seems no one knows for sure if there was any OBD involvement, I don't think there was or it would have been mentioned.
An RNS is so very overdue now addressing the SP crash, director selling which caused it and so many questions that have been discussed on this and other forums. Now there is the MRI scan rollout. What have OBD to say about that?
I still have a holding but won't for much longer if the silence continues
No one doubts the science and medical institutions relationship, what is missing is how and when OBD are moneytising the service/product. That's why shareholder's are selling, they invest to make money. OBD needs to list in the US on a main market, it has zero credibiity as OTC as it is now. It's like AIM only much worse.
Hopefully someone will educate them at this investor meeting.
I've kept some shares in my p/folio just so I don't forget OBD entirely, if they wise up and make the business case as good as the science the SP will rise, stay like it is and they sink.
Potential is fine but how many times do we hear that - too many times, it means nothing
How and when exactly are they going to pull in cash? Thats what investors want to hear.
All the medical science news seems good, all the director sells is not good. Future/present financial strategy unknown.
Investors need to see profits now or where they are coming from, not 'if 's - and that's all there is right now.
ON top of a consistently falling SP
ii has this share as Extreme Risk
I have reduced my holding and invested in safer avenues, like many I think.
I'll be happier if they list on a main market in the US (or sell out to big pharma)
They are good at the science, useless at attracting investment
I've looked at several sites in the US for news, virtually nothing, they are still over the counter shares - virtually no credibility, I thought they were intending to list there.
Dave40 should have waited till next week, get many more for his 2k I would bet going by the past month.
There is no market interest in this now it seems, even share chat here & ADVFN way down, let alone the miserable SP, one of the best days for all markets worldwide and this down over 3% at present.
I don't understand why as it seems a sure thing profit wise and has had good press and RNS's - US Gov and BUPA both signed up. I would like to buy more but I want winners, I'm still in loss territory as I bought on the big news day, I'll hold and hope for a while....
Until some institutions start buying in, the 40 to 30 SP is here to stay looks like, so with all this good news I wonder why there is no interest being shown by big money. Maybe big pharma will make an offer?
I don't get it, so what's the guesses on OBD, any comments welcome.
Well it rhymes! Please leave me out of a slanging match, but I think another RNS is due simply because of all the publicity and investor interest, yes it's only a few days after the 'blockbusters' but there are so many questions investors have right now and the momentum is slipping away to an extent. On Int. Investor, for 3 or 4 days OBD was in the top 10 stocks traded, but not now The silly movements in SP are just irritating to most and just re-affirm how dodgy AIM is.
Mainly I'd like to know what they are doing about the US listing on the main markets, the present OTC/pink slip at present does them no favours, and it's the US that's their biggest potential right now.
AIM renowned for being rubbish mostly and the best place to lose money, I know there are some exceptions and small fry have to start here.
Patience is a virtue but it's an old fashioned concept in this frenzied world - especially here!
I'd like to invest more but although I think it's got great potential, AIM and Pink slip just don't have the necessary credibility, even I think I'm being illogical but it's Once bitten, Twice shy...
Thank you 404x for correcting me about press coverage and for listing the publications which I read with renewed optimism for OBD. I wasn’t trolling btw, simply wrong and stupid for not doing sufficient research, so my apologies to you and all for that. I don’t intend intentionally to ramp or de-ramp at any time. I rarely post anything on any forum but do read them on a share I’m interested in and ask questions I have in the hope of answers to speed up research for which I don’t have the time/knowledge to do. I don’t actually have an axe to grind, it would just be nice to have an investment to have confidence in during this bonkers time in the markets and all else in this world.
I’m not bothered by the Director selling, inho, he is just getting a bit of the fruit of his labour, and knowing (I guess) that he will reap a lot more in time to come.
From the articles published it looks as though we have a wait for regulators – NICE etc. in the UK, but faster in the US. I hope that OBD will list soon on the US main market rather than pink slip/over the counter as at present. Don’t know how long that takes. Lot’s of possible scenario’s still until further hard news from OBD as to future intentions, takeovers etc. It must be a very frantic time for OBD with many options as to future strategy.
It would seem that much more testing needs to take place which will take time to do and evaluate to satisfy various healthcare bodies. I have no idea how long it would take before the PSE test would become as prevalent as the PSA is now.
I’m curious to know if Physiomics have been involved in OBD’s research, it might help their SP…
As for MM’s and their manipulation (as always), I guess we have to just live with the fact that it’s going to be very volatile for a while, and the SP isn’t going to make much sense until further news gives more clarity.
GLA